definiens: shall mean ( i ) the FoundationOne ® clinical diagnostic testing commercial product ( the or ) and the FoundationOne ® Heme clinical diagnostictesting commercial product ( and, together with FoundationOne, collectively, ), ( ii ) the FoundationACT ® clinical diagnostic testing commercial product (, andtogether with the Initial Products, collectively, the ), ( iii ) the FoundationOne CDxTMclinical diagnostic testing commercial product ( or ) and ( iv ) any otherclinical diagnostic testing commercial products developed under the Immunotherapy Testing PlatformDevelopment Program ( as defined in the Collaboration Agreement ), the ctDNA Platform DevelopmentProgram ( as defined in the Collaboration Agreement ), or the CDx Development Program ( as defined inthe Collaboration Agreement ), including, to the extent developed under any such development programunder the Collaboration Agreement, any product that becomes subject to a Regulatory Approval by aRegulatory Authority in the US after the Restatement Date ( clause ( iv ), subject to the terms of Section8.3.5, collectively, ) and ( v ) any other products that the Parties mutually agreeto include under this Agreement